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Edited by Robert Russell and Giulio Superti-FurgaAbstract A long-term goal of the ﬁeld of interactome modeling
is to understand how global and local properties of complex mac-
romolecular networks impact on observable biological proper-
ties, and how changes in such properties can lead to human
diseases. The information available at this stage of development
of the ﬁeld provides strong evidence for the existence of such
interesting global and local properties, but also demonstrates
that many more datasets will be needed to provide accurate mod-
els with increasingly predictive capacity. This review focuses on
an early attempt at mapping a multicellular interactome network
and on the lessons learned from that attempt.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: ORFeome; Interactome; Network biology; Systems
biology; Integrative omics; Reverse two-hybrid system;
Interaction-defective alleles1. Introduction
Macromolecular interactions such as protein–protein, pro-
tein–DNA and protein–RNA interactions are crucial for most
biological processes. Tens of thousands of proteins and other
macromolecules are expressed in a typical cell, mediating per-
haps up to hundreds of thousands of physical interactions at
any given moment, either to form molecular machines [1] or
to participate in various regulatory processes [2]. In this con-
text, the following questions are particularly intriguing. How
are protein interactions organized at the scale of the whole cell?
Could there be global and/or local principles that organize
such complex networks of interactions? If so, how do we start
tackling such topological features of macromolecular net-
works? And importantly, could it be that such organizational
principles are disrupted in human diseases?
Since the beginnings of molecular biology, proteins have
been studied mostly one or a few at-a-time using biochemistry
and genetics. However, it is becoming increasingly clear that
proteins perform their function together in complex networks,
rather than in isolation. The notion of ‘‘interactome’’, deﬁnedAbbreviations: Y2H, yeast two-hybrid system; R2H, reverse two-
hybrid system; HT, high-throughput; DB, DNA binding domain; AD,
activation domain; ORF, open reading frame; EST, expressed
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proteins of an organism, reﬂects a drastic change in the way
biologists have recently started asking fundamental questions.
Indeed, biological questions are increasingly addressed in the
framework of such complex molecular networks.
The completion of the ﬁrst draft of the human genome has
been compared to the discovery expeditions of unknown lands
centuries ago. However, these discovery expeditions were able
to only ‘‘glimpse’’ a fraction of the complexity of the unknown
lands. Indeed, the one-gene/one-protein at-a-time approach of
the last thirty years has provided some indication of function
for only 5–10% of all predicted proteins so far. When we con-
template the draft of the human genome sequence and its
resulting predicted proteome, we are thus facing a gigantic
and daunting unknown territory, a sort of ‘‘terra incognita’’
of modern times. What were the opportunities, challenges
and goals confronted a decade ago, as the genome and tran-
scriptome sequencing projects were launched?
Below I present a view of early eﬀorts at proteome-wide pro-
tein interaction mapping that is biased towards the technolog-
ical development of high-throughput binary assays for
multicellular organisms. As this work was unfolding, protein
interaction maps gradually became available for simpler
organisms from the mid- to late nineties [3–8].2. Lessons from an early attempt
In the early 1990s, genome and transcriptome sequencing ef-
forts were beginning to predict large numbers of completely
uncharacterized proteins. Particularly, the sequence of the ﬁrst
chromosome of Saccharomyces cerevisiae [9] and the ﬁrst few
overlapping cosmids of the Caenorhabditis elegans genome
[10] predicted many genes that had not been identiﬁed by any
classical genetic screens. Likewise, the ﬁrst systematic cDNA
sequencing or ‘‘expressed sequence tags’’ (ESTs) projects re-
vealed large numbers of unstudied gene products [11,12].
As a way to decipher the function of these ‘‘orphan’’ pro-
teins and to determine how they work together in complex cel-
lular networks, in the spring of 1993 I undertook the
development of a high-throughput (HT) system to map and
characterize large numbers of physical protein–protein interac-
tions, making sure that such a system would be applicable to
the study of multicellular organisms, including humans.
At that time, it was clear that the yeast two-hybrid system
(Y2H) [13] provided the only hope to ever generate such global
protein–protein interaction maps. The challenge consisted inblished by Elsevier B.V. All rights reserved.
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not only to the activation domain (AD-cDNA) of the Y2H,
as originally proposed [13] and demonstrated [14,15], but also
to the DNA binding domain (DB-cDNA) of the system. If
somehow one could mix and match DB-cDNA and AD-
cDNA libraries together, very large numbers of potentially
interacting proteins could be identiﬁed using automated,
high-throughput settings, somewhat in the spirit of the starting
EST projects of the time.
A ﬁrst attempt of a DB-library/AD-library screen with
phage lambda genomic DNA [16] demonstrated that, to obtain
biologically interpretable protein interaction maps, a HT DB-
cDNA/AD-cDNA random clone picking and sequencing sys-
tem would require the following features. First, a cleaner
and more stringent version of the Y2H was needed to reduce
the rate of false-positives. To accomplish this, a version of
Y2H with both more ‘‘physiological’’ (or else ‘‘reasonable’’)
levels of expression of DB-X and AD-Y hybrid proteins and
multiple Gal4-responsive reporter genes was developed
[17,18], and tested using numerous bait proteins of particular
biological interest [19–24]. Second, the possibility that DB-
cDNA libraries could be used in the Y2H system needed to
be demonstrated [25]. Third, a robust mating strategy had to
be developed to mix large numbers, i.e. in the range of 105–
106, of DB-cDNA- and AD-cDNA-containing yeast clones
[18,26]. Fourth, a system was needed to eliminate DB-cDNA
auto-activators expected to occur in high proportions
[18,26,27]. Finally, it was clear that procedures would be
needed to allow one, upon ﬁnding DB-X/AD-Y Y2H interac-
tions, to isolate genetic reagents, such as interaction-defective
alleles, or interaction-dissociating peptides or compounds, to
study these interactions back in their natural in vivo environ-
ment [17,18,28–32].
After three years of technology development, the system was
tested using two mouse cDNA libraries, one fused to DB and
the other fused to AD. Thousands of yeast clones, each corre-
sponding to a pair of ‘‘interaction sequence tags’’, or ‘‘ISTs’’,
were recovered. At last, an IST database could now be ob-
tained for the mouse, containing hopefully long lists of ISTij,
deﬁned as DB-ESTi + AD-ESTj, where ESTs are ‘‘expressed
sequence tags’’ and + represents an Y2H interaction. This
was the good news.
The bad news, however, was that these initial ISTs over-
whelmingly corresponded to a single interaction found in both
Y2H orientations: DB-aGlobin + AD-bGlobin and DB-bGlo-
bin + AD-aGlobin [26]. In retrospect, this was an expected re-
sult given the relatively high level of abundance of the
transcripts of these two proteins in most cDNA libraries.
Beyond the ﬁrst deception, two important lessons were
learned from this experiment. First, to completely avoid such
highly abundant ESTs in DB-cDNA and AD-cDNA libraries,
it became clear that comprehensive ‘‘ORFeome’’ cloning pro-
jects needed to be launched, starting from completely se-
quenced and well-annotated genomes [33,34]. Second, even
though a few additional Y2H interactions were found in the
midst of hundreds of DB-aGlobin + AD-bGlobin clones, there
was no way to derive their biological implications strictly from
IST information. Thus it became clear that ‘‘interactome map-
ping’’ projects would have to be performed hand-in-hand with
other functional genomic and proteomic approaches in order
to obtain predictive models of interactome networks. In other
words ‘‘interactome modeling’’ would require many additionallarge-scale approaches for biochemical and genetic character-
ization of the proteome [30,35,36].3. ORFeome cloning
We selected C. elegans as model organism [30] to learn how
complex interactome networks relate to metazoan develop-
ment, because (i) its genome would turn out to be the ﬁrst to
be sequenced for a metazoan [37], and (ii) its cell lineage had
been completely mapped [38]. Thus high quality models of
the complete set of protein-encoding open reading frames, or
‘‘ORFeome’’, could be used to express and characterize most
proteins using multiple approaches to start generating a ‘‘pro-
teome atlas’’ [35] in the context of a nearly perfect ‘‘anatomy
atlas’’.
We adapted the Gateway cloning technology [33,34,39] to
attempt the cloning of all 19 000 predicted C. elegans ORFs
[33,40–42], and more recently of 10 000 human ORFs [43].
Gateway allows eﬃciency and adaptability in HT ORFeome
cloning projects [44,45], by providing ways to directionally
clone PCR products, obtained in our case from a worm cDNA
library as template DNA, into a ‘‘Donor’’ vector. This gener-
ates a ﬂexible resource to transfer the resulting cloned ORFs
into many expression or ‘‘Destination’’ vectors in parallel
(see, e.g., [46]).4. Interactome mapping
C. elegans protein interaction maps were ﬁrst attempted at
the scale of individual biological processes, starting from all
or most proteins known to be involved in these processes, such
as vulval development, proteasome, germline, DNA damage
response and Dauer formation [33,40,47–50]. The combined
data from such ‘‘module-scale’’ interactome mapping attempts
suggested among other things a higher level of interconnectiv-
ity between pathways than originally expected [40].
The properties of the C. elegans interactome network were
then investigated at the scale of the whole proteome [51],
focusing ﬁrst on the subset of predicted worm proteins that
have a clear ortholog in other multicellular organisms, but
not in the yeast S. cerevisiae. From these screens, 4000
Y2H interactions were identiﬁed, representing approximately
5–10% of the C. elegans interactome, a dataset referred to as
WI5. WI5 is a useful resource to predict the function(s) of
thousands of genes. Together with a Drosophila interactome
mapping dataset [52], this work represented the ﬁrst attempt
to characterize a metazoan interactome.
We have recently demonstrated that no matter how primary
Y2H or pull-down/mass-spectrometry screens [53,54] are con-
ducted, the overall quality of an interactome dataset can be im-
proved by systematically incorporating multiple data sets [55]
or by retesting the ‘‘edges’’ of a network by diﬀerent, orthog-
onal, secondary interaction assays [51]. The ﬂexibility of the
Gateway cloning system allows the transfer of thousands of
ORFs at-a-time into diﬀerent vectors that can then be used
for secondary binary interaction assays. In our recent interac-
tome map [51], we were able to show that 65% of the Y2H
edges retested positive in a single co-aﬃnity pull down assay
performed in mammalian cells. In a recent experiment, we
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of the human TGFb pathway, out of which 17 retested positive
after only one attempt at the co-aﬃnity pull down assay, cor-
responding to 90% retest [50].
While repeating directly either Y2H or pull-down/mass spec-
trometry assays can conﬁrm initial observations and demon-
strate reproducibility of a speciﬁc assay system [53], it goes
without saying that testing the same interaction with two dif-
ferent assays is much more stringent than repeating the same
procedure twice.5. Comparative interactomics
A protein interaction map should be beneﬁcial not only in
the context of the species it was ﬁrst intended for, but also
for biologists involved in the study of other species. To test this
idea we investigated to what extent the proteome-scale interac-
tome map generated for yeast [5,7] could help making predic-
tions of interactions for C. elegans. For each protein partner
pair corresponding to a set of potential yeast interactions, we
searched in silico for pairs of respective orthologs, or ‘‘intero-
logs’’ [33], in C. elegans [56]. Approximately 20% of such worm
potential interologs gave rise to detectable Y2H read-outs.
Compared to experiments performed with randomly selected
protein pairs tested in various two-hybrid settings, this number
represents more than a 2000-fold increase.
We concluded that interologs are reasonable predictors of
protein–protein interactions. Altogether, these observations
suggested that protein interaction maps generated for a few
model organisms might be useful to study, and may be design
therapeutic strategies against, a large number of other organ-
isms such as parasites and pathogens. Recent work further
exempliﬁed the potential power of such interolog searches [57].6. Interactome modeling
Attempts have been described to model the function and
dynamics of interactome networks by integrating various func-
tional genomic approaches such as expression proﬁling and
genome-wide phenotypic proﬁling generated by gene knock-
outs or RNA interference experiments. One should keep in
mind that interactome mapping approaches have intrinsic
caveats. For example, information is often missing because
of the occurrence of false negatives, and information can be
misleading because of the presence of false positives. Thus,
data obtained from any single interactome mapping approach
should be interpreted cautiously. In addition, data emerging
from any single Y2H interaction can only indicate the possibil-
ity of related functions between two proteins, but does not
constitute deﬁnitive proof.
It has been proposed that these limitations can be overcome
by integrating data obtained from two or more distinct ap-
proaches [30,35,36]. For example, a Y2H interaction between
two proteins whose genes are co-expressed under various
experimental conditions and show overlapping loss-of-func-
tion phenotypes is more likely to be relevant in vivo than
any interaction for which this additional information is not
available. Recent investigations of the relationships between
data sets obtained using distinct omic approaches demon-strated the use of such integrated approaches to model the
interactome, thereby improving the analysis of biological sys-
tems [48,49,58–62].7. Interaction-defective alleles and reverse two-hybrid system
To fully make use of interactome models it is important to
develop HT strategies to validate potential protein–protein
interactions back in the biologically relevant settings. A genetic
strategy that can be used to validate potential interactions is to
identify single amino-acid change that speciﬁcally aﬀect one
interaction while leaving all other known interactions intact.
Such interaction-defective alleles (IDAs) can be tested for their
ability to function either in vitro or in vivo [18]. Similarly
trans-acting dissociators such as peptides or compounds could
also be used. Correlation between loss-of-interaction and loss-
of-function provides strong evidence of biological relevance
for a potential interaction [33].
Integrated approaches are available for HT selection and
manipulation of IDAs without the need for any structural
information on the proteins involved [17,28,32]. Such ap-
proaches are based on a modiﬁed version of the reverse two-
hybrid system (R2H). Of particular interest, the use of the
Green Fluorescent Protein [63] as a C-terminal tag allows
the recovery of single amino-acid substitutions that speciﬁcally
prevent interaction rather than non-sense mutations that en-
code truncated proteins. In addition, the Gateway recombina-
tional cloning technique can be used to rapidly transfer IDAs
from the yeast assay into diﬀerent expression vectors allowing
subsequent characterization [32]. This integrated version of the
R2H is amenable to automation, which is important con-
sidering the large numbers of potential interactions already
available.8. Conclusions
Altogether the work performed in both unicellular and mul-
ticellular organisms has shown that a systematic approach to
the challenge of globally mapping interactome networks is pos-
sible and can be highly informative. At this stage, the technol-
ogy should be suﬃciently mature to start analyzing the human
interactome network at the proteome-scale. Among future
goals, we can now focus on studying the evolution of interac-
tome networks, by comparing those of yeast, C. elegans, Dro-
sophila and humans, and understanding cellular organizational
principles of the human interactome. An interesting approach
would be to study the global eﬀects of viral proteomes upon
infection into their host cells. Is it possible that evolution has
shaped global strategies employed by viral proteomes to re-
wire the hosts cellular networks and by doing so, forcing the
host to reorganize its cellular activities?
Among the major challenges of the ﬁeld of interactomics is
the fact that the proteome is a dynamic entity. In terms of
deﬁning the human genome nucleotide sequence, the Human
Genome Project was a ﬁnite enterprise. In contrast, it is harder
to deﬁne the ultimate goal of a ‘‘human interactome project’’.
Indeed, there are as many ‘‘sub’’-proteomes in the human body
as there are cells and conditions. In other words, the proteome
is constantly changing through time and space. Future ver-
M. Vidal / FEBS Letters 579 (2005) 1834–1838 1837sions of interactome maps will have to take this dimension into
account.
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